Case reports: treatment of atypical hidradenitis suppurativa with the tumor necrosis factor receptor-Fc fusion protein etanercept.
We present a case where etanercept--a soluble tumor necrosis factor receptor-Fc fusion protein-was safe and effective in treating the painful skin lesions of a 24-year-old patient with hidradenitis suppurativa, resulting in an improvement in quality of life.